Skip to content
  • About
  • Contact
  • Our Staff
  • Advertise
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Novo Nordisk

Novo Nordisk Rises to the Global Top Five as Ozempic and Wegovy Redefine Obesity Care
Posted in
  • Case Studies & Trends
  • Industry Landscape
  • Uncategorized

Novo Nordisk Rises to the Global Top Five as Ozempic and Wegovy Redefine Obesity Care

You can track shifts in global healthcare by watching where capital flows, how prescribers modify their … Novo Nordisk Rises to the Global Top Five as Ozempic and Wegovy Redefine Obesity CareRead more

by Gurinder Khera•November 19, 2025November 19, 2025•0
How AI is Transforming Drug Discovery: A Look at Immunai’s Partnership with Pfizer and Novo Nordisk
Posted in
  • Digital Transformation
  • Industry Landscape
  • Regulatory Compliance

How AI is Transforming Drug Discovery: A Look at Immunai’s Partnership with Pfizer and Novo Nordisk

In recent years, artificial intelligence (AI) has moved from the realm of speculative fiction into a … How AI is Transforming Drug Discovery: A Look at Immunai’s Partnership with Pfizer and Novo NordiskRead more

by Gurinder Khera•September 16, 2025September 16, 2025•0

Recent Posts

  • Dynamic Rep Routing for Lower Travel and Higher Reach: How AI Is Transforming Pharma Field Force Strategy
  • How to Build Local KOL Networks in Pharma Using Digital Tools
  • How Marketing Automation Transforms Field Medical Teams for Better HCP Outreach
  • Predictive Lead Scoring in Pharma: A Data-Driven Guide for Inside Sales Leaders
  • Sustainability Messaging in Pharmaceutical Advertising

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A